Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma

被引:123
作者
de Perrot, M
Licker, M
Bouchardy, C
Usel, M
Robert, J
Spiliopoulos, A
机构
[1] Univ Hosp Geneva, Dept Surg, Thorac Surg Unit, CH-1211 Geneva 14, Switzerland
[2] Univ Hosp Geneva, Div Anesthesiol, CH-1211 Geneva 14, Switzerland
[3] Geneva Canc Registry, Geneva, Switzerland
关键词
D O I
10.1016/S0022-5223(00)70213-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective and methods: To characterize gender differences in lung cancer, we conducted a retrospective analysis including all patients undergoing surgery for non-small cell lung carcinoma in a single institution over a 20-year period. Results: Compared with men (n = 839), women (n = 198) were more likely to be asymptomatic (32% vs 20%, P =.006), nonsmokers (27% vs 2%, P <.001), or light smokers (31 pack-years vs 52 pack-years; P <.001), Squamous cell carcinoma predominated in men (65%), and adenocarcinoma predominated in women (54%), Preoperative bronchoscopy contributed more frequently to a histologic diagnosis in men (69% vs 49% in women, P <.001), and fewer pneumonectomies were performed in women (22% vs 32% in men, P =.01). After multivariate Cox regression analysis, women survived longer than men (hazard ratio, 0.72; 95% confidence interval, 0.56-0.92; P =.009) independently of age, presence of symptoms, smoking habits, type of operation, histologic characteristics, and stage of disease. The protective effect linked to female sex was present in early-stage carcinoma (stage I and II) and absent in more advanced-stage carcinoma (stage III and IV). Conclusions: This study emphasizes strong sex differences in presentation, management, and prognosis of patients with non-small cell lung cancer.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 30 条
[1]  
[Anonymous], INT CLASS DIS ONC
[2]  
[Anonymous], IARC SCI PUBLICATION
[3]   Cigarette smoking and histologic type of lung cancer in men [J].
Barbone, F ;
Bovenzi, M ;
Cavallieri, F ;
Stanta, G .
CHEST, 1997, 112 (06) :1474-1479
[4]  
BEATTIE CW, 1985, CANCER RES, V45, P4206
[5]  
BOUCHARDY C, 1997, IARC SCI PUBL, V143, P666
[6]  
BOUCHARDY C, IN PRESS CANCER
[7]  
BRYD RB, 1969, THORAX, V24, P573
[8]  
CAGLE PT, 1990, CANCER RES, V50, P6632
[9]   Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer [J].
Caltagirone, S ;
Ranelletti, FO ;
Rinelli, A ;
Maggiano, N ;
Colasante, A ;
Musiani, P ;
Aiello, FB ;
Piantelli, M .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (01) :51-59
[10]  
CANVER CC, 1994, J THORAC CARDIOV SUR, V108, P153